Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/SC/Myrtle Beach
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Myrtle Beach, SC

Studies commonly pay $75 to $4,500 per completed study

88 clinical trials are currently recruiting participants within 30 miles of Myrtle Beach. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

88studies recruiting
6+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Myrtle Beach right now

Top 25 of 88 recruiting studies, sorted by proximity — each links to its official registry page

ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

Transitional Cell Cancer of Renal Pelvis and Ureter Phase 3 Interventional 100 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Steba Biotech S.A.
See eligibility & contact on ClinicalTrials.gov (NCT04620239)

STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking

Tobacco Use, Substance Use Disorders N/A Interventional 240 participants sought
Shoreline Behavioral Health Services — Conway, South Carolina (12.8 mi) · Sponsor: Medical University of South Carolina
See eligibility & contact on ClinicalTrials.gov (NCT06922617)

An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Metastatic Hormone-sensitive Prostate Cancer Phase 2 Interventional 150 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06991556)

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG Phase 2 Interventional 90 participants sought
Site 02-006 - Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Theralase® Technologies Inc.
See eligibility & contact on ClinicalTrials.gov (NCT03945162)

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

High-risk Muscle Invasive Urothelial Carcinoma Phase 3 Interventional 915 participants sought
Research Site — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07720284)

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Non-muscle-invasive Bladder Cancer, NMIBC Phase 1 Interventional 55 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Aura Biosciences
See eligibility & contact on ClinicalTrials.gov (NCT05483868)

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Metastatic Castration-resistant Prostatic Neoplasms Phase 3 Interventional 1,203 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07164443)

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Non-Muscle Invasive Bladder Neoplasms Phase 3 Interventional 641 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06319820)

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

Alopecia Areata Phase 3 Interventional 1,330 participants sought
Alliance for Multispecialty Research, LLC — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06873945)

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostatic Neoplasms, Castration-Resistant Phase 3 Interventional 800 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07225946)

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

Metastatic Hormone-sensitive Prostate Cancer (mHSPC) Phase 1 Interventional 60 participants sought
South Texas Accelerated Research Therapeutics - Carolinas — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Amgen
See eligibility & contact on ClinicalTrials.gov (NCT07140900)

RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

Pain N/A Observational 4,800 participants sought
Channel Research — Pawleys Island, South Carolina (23.5 mi) · Sponsor: Boston Scientific Corporation
See eligibility & contact on ClinicalTrials.gov (NCT01719055)

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ Phase 1, Phase 2 Interventional 350 participants sought
Carolina Urologic Research Center, LLC — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: enGene, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04752722)

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC) Phase 1 Interventional 453 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT03460977)

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Bladder Carcinoma, Ureter Carcinoma N/A Observational 2,020 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Guardant Health, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05059444)

Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

Prostate Cancer Detection N/A Observational 500 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Sequenom, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07543757)

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Prostate Cancer Patients Treated by Radiotherapy, Prostate Cancer (Adenocarcinoma) Phase 2 Interventional 45 participants sought
START Carolinas — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Candel Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07332000)

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Non-muscle Invasive Bladder Cancer Phase 1 Interventional 294 participants sought
Grand Strand Medical Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07206225)

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

High-Risk Non-Muscle-Invasive Bladder Cancer Phase 2 Interventional 325 participants sought
Carolina Urologic Research Center, LLC — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: CG Oncology, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06567743)

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

Solid Tumor Cancer, Locally Advanced Phase 1, Phase 2 Interventional 355 participants sought
Avenzo Therapeutics Recruiting Site — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Avenzo Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07193511)

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Metastatic Castration-Resistant Prostate Cancer Phase 2 Interventional 75 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Kyntra Bio
See eligibility & contact on ClinicalTrials.gov (NCT06842498)

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Advanced Solid Tumor, Metastatic Solid Tumor Phase 1 Interventional 220 participants sought
Investigative Site #107 — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: MOMA Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06545942)

A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)

Overweight, Obesity Phase 2 Interventional 872 participants sought
TMA Headlands LLC (d/b/a Trial Management Associates) — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07575932)

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer Phase 2 Interventional 218 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi) · Sponsor: Astellas Pharma Global Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07005154)
Actively enrolling

Studies you may be able to join near Myrtle Beach

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Myrtle Beach

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

START Carolinas

★ 4.7
823 82nd Pkwy suite b, Myrtle Beach, SC 29572
(843) 839-1679
"Initial conference for stone removal. Didn’t learn anything I hadn’t already learned from the internet. In a holding pattern for surgery scheduling."
— Happy Jack, 4★

Advanced Clinical Trials

★ 5.0
291 SC-90 #291e, Little River, SC 29566
(843) 249-4129

Body Revolution Aesthetics & Wellness

★ 5.0
1211 48th Ave N, Myrtle Beach, SC 29577
(843) 213-1633

Coastal Carolina Research Center

★ 4.4
4920 O'Hear Ave Ste 101, North Charleston, SC 29405
(843) 856-3784
"I feel Coastal Carolina is a valuable asset to the research community in the Charleston area. They are extremely welcoming and professional. Their ex…"
— Pam, 5★

Little River Medical Center

★ 4.4
4220 Carolina Exchange Dr, Myrtle Beach, SC 29579
(843) 663-8000
"Dr. Insignares is a great face for LRMC. With him, it is all about the patient—like it used to be!"
— ElizabethT, 5★

Clinical Research Center Of The Carolinas

1364 Ashley River Rd, Charleston, SC 29407
(843) 375-8111

Clinical trials in Myrtle Beach: what's recruiting

The Myrtle Beach area currently has 88 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Myrtle Beach, the most active research areas are:

  • Cancer & Oncology17 studies
  • Liver & Kidney2 studies
  • Immune & Skin1 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Myrtle Beach, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Myrtle Beach

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Myrtle Beach participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Myrtle Beach pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
How do I join a study in Myrtle Beach, SC?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Myrtle Beach?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Myrtle Beach typically complete one or two studies per year.

Paid clinical trials near Myrtle Beach

Other metros within reach

Wilmington, NC114 Fayetteville, NC124 Charleston, SC731 Columbia, SC189 Cary, NC1,684 Raleigh, NC1,677 Durham, NC1,684 Concord, NC635

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Myrtle Beach Bladder Issues Due To Spinal Cord Injury in Myrtle Beach All conditions

More of SC

Charleston731 Rock Hill593 Greenville372 Mauldin370 Spartanburg357 Columbia189

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts